Samuel J. Reich

This profile gathers the share dealings of Samuel J. Reich across 2 companies, led by SAB Biotherapeutics, Inc. and Opko Health, Inc. Between 29 March 2007 and 29 November 2023, the trades on record add up to 6 filings.

The open-market record is one-sided, with 3 purchases worth €3.4M and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2023, the count stands at 1 purchase and no sales.

Half of the purchases are above €8,942 and half below. 3 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The latest filing, published on 30 November 2023, reports an open-market purchase of €8,942 in SAB Biotherapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.